Skip to main content
Have a personal or library account? Click to login
From Trendelenburg to PERTs: Evolution in the Management of Massive Pulmonary Embolism Cover

From Trendelenburg to PERTs: Evolution in the Management of Massive Pulmonary Embolism

By:   
Open Access
|May 2024

References

  1. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e419S-e496S. doi: 10.1378/chest.11-2301
  2. Jaff MR, McMurtry MS, Archer SL, et al.; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation. 2011 Apr 26;123(16):1788-830. doi: 10.1161/CIR.0b013e318214914f
  3. Konstantinides SV, Meyer G, Becattini C, et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405
  4. Kwok CS, Wonng CW, Lovatt S, Myint PK, Loke YK. Misdiagnosis of pulmonary embolism and missed pulmonary embolism: A systematic review of the literature. Health Sci Rev. 2022 Jun;3:1-6. doi: 10.1016/j.hsr.2022.100022
  5. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. doi: 10.1016/j.amepre.2009.12.017
  6. Martin KA, Molsberry R, Cuttica MJ, Desai KR, Schimmel DR, Khan SS. Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018. J Am Heart Assoc. 2020 Sep;9(17):e016784. doi: 10.1161/JAHA.120.016784
  7. Hsu SH, Ko CH, Chou EH, et al. Pulmonary embolism in United States emergency departments, 2010–2018. Sci Rep. 2023 Jun 5;13(1):9070. doi: 10.1038/s41598-023-36123-2
  8. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013 Spring;18(2):129-38. PMID: 23940438
  9. Jaureguízar A, Jiménez D, Bikdeli B, et al.; Registro Informatizado de la Enfermedad TromboEmbólica Investigators. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism. Chest. 2022 Feb;161(2):524-534. doi: 10.1016/j.chest.2021.08.059
  10. Keller K, Coldewey M, Geyer M, Beule J, Balzer JO, Dippold W. Shock index for outcome and risk stratification in acute pulmonary embolism. Artery Res. 2016 Jun 7;15:30-35. doi: 10.1016/j.artres.2016.05.002
  11. Vanni S, Jiménez D, Nazerian P, et al. Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate. Thorax. 2015 Apr;70(4):333-8. doi: 10.1136/thoraxjnl-2014-206300
  12. Ebner M, Pagel CF, Sentler C, et al. Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism. Eur J Intern Med. 2021 Apr;86:25-31. doi: 10.1016/j.ejim.2021.01.021
  13. Bangalore S, Horowitz JM, Beam D, et al. Prevalence and Predictors of Cardiogenic Shock in Intermediate-Risk Pulmonary Embolism: Insights From the FLASH Registry. JACC Cardiovasc Interv. 2023 Apr 24;16(8):958-972. doi: 10.1016/j.jcin.2023.02.004
  14. White PD. The acute cor pulmonale. Ann Int Med. 1935;9:115. doi: 10.7326/0003-4819-9-2-115
  15. Zuin M, Rigatelli G, Carraro M, et al. Systemic thrombolysis in haemodynamically unstable pulmonary embolism: The earlier the better? Thromb Res. 2019 Jan;173:117-123. doi: 10.1016/j.thromres.2018.11.029
  16. Zieliński D, Dyk W, Wróbel K, Biederman A. Surgical pulmonary embolectomy: state of the art. Kardiochir Torakochirurgia Pol. 2023 Jun;20(2):111-117. doi: 10.5114/kitp.2023.130019
  17. Mack I, Beall AC, Griffith GC, Rosenberg DML, Sampson JJ. Salvaging the patient with acute massive pulmonary embolism. Dis Chest. 1962 Dec;42(6)L584-95. doi: 10.1378/chest.42.6.584
  18. Sosa DF, Lehr AL, Zhao H, et al. Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis. Eur Respir Rev. 2022 Jul 12;31(165):220023. doi: 10.1183/16000617.0023-2022
  19. Wiske CP, Shen C, Amoroso N, et al. Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teams. J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):717-724. doi: 10.1016/j.jvsv.2019.12.077
  20. Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk Stratification in Patients with Acute Pulmonary Embolism: Current Evidence and Perspectives. J Clin Med. 2022 Apr 30;11(9):2533. doi: 10.3390/jcm11092533
  21. Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014 Sep;44(3):694-703. doi: 10.1183/09031936.00006114
  22. Chen X, Shao X, Zhang Y, et al. Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2020 Sep;193:99-106. doi: 10.1016/j.thromres.2020.05.047
  23. Schouver ED, Chiche O, Bouvier P, et al. Diuretics versus volume expansion in acute submassive pulmonary embolism. Arch Cardiovasc Dis. 2017 Nov;110(11):616-625. doi: 10.1016/j.acvd.2017.01.016
  24. Ducas J, Prewitt RM. Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism. Cardiovasc Clin. 1987;17:191-202. PMID: 3536103.
  25. Sekhri V, Mehta N, Rawat N, Lehrman SG, Aronow WS. Management of massive and nonmassive pulmonary embolism. Arch Med Sci. 2012 Dec 20;8(6):957-69. doi: 10.5114/aoms.2012.32402
  26. Capellier G, Jacques T, Balvay P, et al. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med. 1997 Oct;23(10):1089-92. doi: 10.1007/s001340050461
  27. Bhat T, Neuman A, Tantary M, et al. Inhaled nitric oxide in acute pulmonary embolism: a systematic review. Rev Cardiovasc Med. 2015;16(1):1-8. doi: 10.3909/ricm0718
  28. Raschke R, Reilly BM, Srinivas S, et al. The weight based heparin dosing nomogram versus a standard care nomogram: a randomized controlled trial. Ann Intern Med. 1993 Nov 1;119(9):874-81. doi: 10.7326/0003-4819-119-9-199311010-00002
  29. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis. 1995;2(3):227-9. doi: 10.1007/BF01062714
  30. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002 Oct 10;347(15):1143-50. doi: 10.1056/NEJMoa021274
  31. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation. 2006 Jan 31;113(4):577-82. doi: 10.1161/CIRCULATIONAHA.105.592592
  32. Pasrija C, Kronfli A, George P, et al. Utilization of Veno-Arterial Extracorporeal Membrane Oxygenation for Massive Pulmonary Embolism. Ann Thorac Surg. 2018 Feb;105(2):498-504. doi: 10.1016/j.athoracsur.2017.08.033
  33. Pasrija C, Shah A, George P, et al. Triage and optimization: A new paradigm in the treatment of massive pulmonary embolism. J Thorac Cardiovasc Surg. 2018 Aug;156(2):672-681. doi: 10.1016/j.jtcvs.2018.02.107
  34. Elbadawi A, Mentias A, Elgendy IY, et al. National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism. Vasc Med. 2019 Jun;24(3):230-233. doi: 10.1177/1358863X18824650
  35. Engelman DT, Steingrub J. Is venoarterial extracorporeal membrane oxygenation the first-line therapy for massive pulmonary embolus with end-organ dysfunction? J Thorac Cardiovasc Surg. 2018 Aug;156(2):682-683. doi: 10.1016/j.jtcvs.2018.03.024
DOI: https://doi.org/10.14797/mdcvj.1345 | Journal eISSN: 1947-6108
Language: English
Page range: 19 - 26
Submitted on: Jan 17, 2024
Accepted on: Mar 27, 2024
Published on: May 16, 2024
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2024 Pavan Thangudu, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.